NEW YORK (Reuters Health) – Using a new approach to detect tumor-associated plasma proteins, Canadian researchers have discovered a novel biomarker that may improve the diagnosis of lung…
NEW YORK (Reuters Health) – In an unselected cohort of female patients aged 4 to 15 years old with no reported history of sexual contact, more than one…
NEW YORK (Reuters Health) – Breast cancers that are ER/PR negative and HER-2/neu nonamplified are more likely than those without triple negative status to show a complete pathologic…
NEW YORK (Reuters Health) – High urinary levels of a carcinogen in tobacco may help predict risk of lung cancer in smokers, according to research reported at the…
NEW YORK (Reuters Health) – The two commercially available Mycobacterium tuberculosis-specific interferon-gamma release assays show excellent agreement with each other. As far more accurate indicators of latent TB…
NEW YORK (Reuters Health) – The results of a postmortem study indicate that elderly people who commit suicide usually do not have antidepressant medications in their systems at…
NEW YORK (Reuters Health) – From 1985 to 2007, the initial CD4+ cell counts seen at diagnosis in HIV-infected patients in the US have fallen, suggesting that the…
NEW YORK (Reuters Health) – Women with synchronous primary ovarian and endometrial cancers have better survival rates than women with single ovarian cancers do, according to a report…
NEW YORK (Reuters Health) – Annual ovarian cancer screening with transvaginal ultrasonography and CA 125 usually misses early-stage disease while it often results in unneeded surgeries, according to…
NEW YORK (Reuters Health) – Using a novel high-throughput screening assay, a team of scientists has discovered that two highly virulent viruses are susceptible in vitro to the…